Nephros (NEPH) Accounts Payables (2010 - 2026)
Nephros (NEPH) posted quarterly Accounts Payables of $1.5 million for Q1 2026, up 162.66% year-over-year from $557000.0 in Q1 2025, and up 60.07% quarter-over-quarter from $914000.0 in Q4 2025.
Nephros (NEPH) Accounts Payables (2010 - 2026) Analysis & Trends
Nephros' Accounts Payables history runs 17 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Accounts Payables rose 162.66% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (up 162.66% YoY), while the FY2025 annual figure was $914000.0, up 40.83% from the prior year.
- Accounts Payables for Q1 2026 stood at $1.5 million, up from $914000.0 in the prior quarter.
- The five-year high for Accounts Payables was $1.5 million in Q1 2026, with the low at $302000.0 in Q2 2023.
- The 5-year median for Accounts Payables is $805000.0 (2023), against an average of $844000.0.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables slumped 78.6% in 2023, then jumped 283.77% in 2024.
- Nephros' Accounts Payables stood at $740000.0 in 2022, then gained by 17.97% to $873000.0 in 2023, then fell by 25.66% to $649000.0 in 2024, then surged by 40.83% to $914000.0 in 2025, then soared by 60.07% to $1.5 million in 2026.
- Business Quant data shows NEPH's Accounts Payables at $1.5 million in Q1 2026, $914000.0 in Q4 2025, and $936000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 133.48 Bn | 128.26 Bn | 1.96 Bn | 277.20 Mn |
| 2 | Becton Dickinson | 52.15 Bn | 51.29 Bn | 2.32 Bn | 6.11 Bn |
| 3 | Alcon | 35.59 Bn | 34.24 Bn | 1.68 Bn | 968.00 Mn |
| 4 | Resmed | 33.67 Bn | 32.20 Bn | 861.22 Mn | 308.92 Mn |
| 5 | Medline | 28.56 Bn | 25.88 Bn | 2.22 Bn | 1.04 Bn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | 252.70 Mn |
| 7 | Solventum | 15.34 Bn | 14.94 Bn | 1.29 Bn | 701.00 Mn |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | 233.30 Mn |
| 9 | Baxter International | 13.59 Bn | 11.44 Bn | 1.03 Bn | 1.03 Bn |
| 10 | Nephros | 46.36 Mn | 41.66 Mn | 4.03 Mn | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.97 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 914,000.00 |
| Sep 30, 2025 | 936,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Mar 31, 2025 | 557,000.00 |
| Dec 31, 2024 | 649,000.00 |
| Sep 30, 2024 | 398,000.00 |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 873,000.00 |
| Sep 30, 2023 | 805,000.00 |
| Jun 30, 2023 | 302,000.00 |
| Mar 31, 2023 | 719,000.00 |
| Dec 31, 2022 | 740,000.00 |
| Sep 30, 2022 | 779,000.00 |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 897,000.00 |
| Dec 31, 2021 | 1.33 Mn |
| Sep 30, 2021 | 641,000.00 |